The announcement of a securities fraud lawsuit against Elanco Animal Health is likely to negatively impact its stock price in the short term due to potential legal liabilities and investor concerns. The deadline for lead plaintiff applications suggests ongoing legal proceedings, which can create uncertainty and pressure on the stock.